Dr. Martens Plc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Ije Nwokorie
- Full Time Employees
- 2,377
- Sector
- Consumer non-durables
- Industry
- Apparel/Footwear
- Address
- 28 Jamestown Road London GL United Kingdom NW1 7BY
- IPO Date
- Jan 29, 2021
- Website
- drmartensplc.com
- Similar Companies
- Business
- Dr. Martens plc designs, develops, procures, markets, sells and distributes footwear, apparel and accessories under the iconic Dr. Martens brand; its core products encompass boots including the signature 1460 and 1461 models, shoes such as the Adrian tassel loafer, sandals, bags featuring silhouettes like the Kiev backpack and heart-shaped designs, and other accessories encompassing socks, laces and shoe care items. Founded in 1960 with the launch of the original 1460 boot in Wollaston, England, the company, headquartered in London at 28 Jamestown Road, Camden, operates across three primary regions—EMEA, Americas and APAC—with regional hubs in Portland for the Americas and Hong Kong for APAC, and additional facilities in locations including Northamptonshire, Paris, New York, Tokyo and Ho Chi Minh City; it serves consumers in more than 60 countries through direct-to-consumer channels like 239 owned stores and e-commerce platforms alongside wholesale and distributor partnerships. The company targets diverse demographics seeking durable, self-expressive footwear blending workwear heritage and contemporary fashion, with recent strategic shifts including the adoption of a consumer-first Levers for Growth strategy emphasizing new product families like Zebzag laceless boots, Buzz, and waterproof 1460 Rain boots that drove 33% shoe volume growth in H1 FY26; expansions via distribution partnerships with Beside Group for UAE market entry, Crosby for Latin America including new stores in Chile and Argentina, and agreements in Italy and the Philippines; operational enhancements through a new Global Technology Centre in India, supply and demand planning systems, and simplified partnerships with key wholesalers in the USA and South Korea.
Company News
Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
Dr Martens profits jump as turnaround gains grip
Dr Martens' turnaround gathers pace as annual profit jumps 61%
FTSE 100 Live: London stocks climb as HSBC becomes largest company
FTSE 100 Live: London stocks climb with HSBC taking crown as largest company
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
FTSE 100 Live: Stocks start higher with Sage in the lead, Dr Martens down
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
Dr Martens sales growth slows but 'significant' profit increase still expected
Dr. Martens plc (DRMTY) Q2 2026 Earnings Call Transcript
Dr Martens drops despite results in line with forecasts
Dr Martens back on its feet
Dr Martens tiptoes higher after positive America retail trading, UK still challenging
Dr. Martens: Iconic Brand At A Potential Bargain
Dr Martens surges 23% as investors lace up for recovery story
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr Martens marketing 'reset' saw annual revenue and profit retreat, eyes return to growth this year
Dr Martens interims a first test for new CEO after shares stumble to all-time low
Dr. Martens Selects Amperity to Transform Customer Data Strategy
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript